skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines vandetanibQuestion & answer

vandetanib · Medicine question

What is the minimum approved age for vandetanib (Caprelsa) treatment?

iatroX medicinesPublished 8 November 2026

The answer

Answer

The minimum approved age for vandetanib (Caprelsa) treatment is 5 years.

Sources for this answer

Caprelsa 300 mg film-coated tabletsSANOFI · emc · SmPC §4.1 Therapeutic Indications · Version 9Document updated 25 March 2026

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

vandetanib

Read the wider context, including uses, precautions and the sources behind this medicine guide.

More questions about vandetanib

Can vandetanib cause heart failure?Has fatal interstitial lung disease been reported with vandetanib?How does vandetanib affect metformin exposure?Is concomitant use of vandetanib and ondansetron recommended?Should concomitant use of vandetanib and St John's wort be avoided?Which potentially life-threatening severe skin reactions have been reported with vandetanib?

Read the vandetanib guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX